Physician profile
Tara Lynn Spivey
NPI 1861756512
$4,152.24
in general payments reported to CMS, 2019-2025
8 companies · $763 in 2025
The $763 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $2,600 · 2022: $110 · 2023: $40.03 · 2024: $157 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $763 · Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $762.76 |
| Food and Beverage | $197.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $2,600.00 | 2020 | |
| Hologic INC | $762.76 | 2025 | Magtrace |
| Pacira Pharmaceuticals Incorporated | $482.68 | 2019 | |
| Tactile Systems Technology INC | $114.41 | 2024 | Entre Plus, Flexitouch Plus |
| Lilly USA, LLC | $109.66 | 2022 | |
| Endomagnetics LTD | $47.12 | 2023-2024 | Magtrace, Magseed |
| Impedimed, INC. | $21.15 | 2024 | |
| Medtronic, INC. | $14.46 | 2023 | Plasmablade(Tm) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Spivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.